Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Nicox announces licensing agreement with Eyevance for commercialization of ZERVIATETM in the United States
-
Titan Pharmaceuticals To Present At Cantor Fitzgerald Global Healthcare Conference
-
Nabriva Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Nobilis Health to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Celyad to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Corvus Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
Sangamo Therapeutics Announces Presentation At The 2017 Cantor Fitzgerald Global Healthcare Conference
-
Dermira to Present at Cantor Fitzgerald Global Healthcare Conference
-
Genesis HealthCare to Present at the Cantor Fitzgerald Global Healthcare Conference on September 25, 2017
-
U.S. Physical Therapy to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
Pre-Open Stock Movers 09/20: (ALNY) (KPTI) (GEMP) Higher; (BBBY) (IONS) (GIS) Lower (more...)
-
Cascadian Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Cerus to Present at Cantor Fitzgerald’s Annual Healthcare Conference on September 27, 2017
-
Progenics Pharmaceuticals to Present at the Cantor Fitzgerald 2017 Global Healthcare Conference
-
Fennec to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017 in New York City
-
Veru Inc. to Present at Two Financial Conferences in September
-
iCAD to Present at the Cantor Fitzgerald Global Healthcare Conference
-
BioSpecifics Technologies Corp. to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
Genocea to Present at Cantor Fitzgerald Healthcare Conference
-
Xencor to Present at Upcoming Investor Conferences
-
Aldeyra Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference
-
Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference
-
Calithera Biosciences to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference and the Leerink Partners Immuno-Oncology Roundtable
-
Pacira Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017
-
Ra Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Ignyta to Present at Cantor Fitzgerald 2017 Global Healthcare Conference
-
BioTime to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Stemline Therapeutics to Present at Upcoming Investor Conferences
-
Sierra Oncology to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
Syndax Pharmaceuticals Announces Updated Presentation Time at the Cantor Fitzgerald Global Healthcare Conference
-
OraSure Technologies to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
After-Hours Stock Movers 09/19: (KOOL) (GEMP) (CBAY) Higher; (BBBY) (IOVA) (ADBE) Lower (more...)
-
Mirati Therapeutics To Present At Upcoming Healthcare Conferences
-
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Starts CymaBay Therapeutic (CBAY) at Overweight
-
Exelixis to Present at the Cantor Fitzgerald Healthcare Conference on September 25
-
Theravance Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Luminex Corporation To Present At Cantor Fitzgerald's Global Healthcare Conference
-
Revance to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference
-
Apollo Endosurgery to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Nicox to present at the Cantor Fitzgerald 2017 Global Healthcare Conference
-
Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference
-
Matinas BioPharma to Present at the Cantor Fitzgerald Global Healthcare Conference
-
MEI Pharma to Present at Cantor Fitzgerald Global Healthcare Conference
-
Aldeyra Therapeutics (ALDX) Prices 3.45M Common Stock Offering at $7.25/Share
-
Aldeyra Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
-
Albireo to Present at Investor Conferences in September
-
Impax to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Abaxis, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference

